Granules India Limited received FDA approval of its abbreviated new drug application for loperamide hydrochloride and simethicone tablets indicated for diarrhea symptom relief, according to a press release.The FDA determined that, among adult patients with symptoms of diarrhea, bloating, pressure and cramps, Granules India’s loperamide hydrochloride and simethicone (2 mg/125 mg) product is therapeutically equivalent to Johnson & Johnson’s Imodium Multi-Symptoms Relief Tablets (2 mg/125 mg), which was used as a reference product.According to the FDA, the most common adverseRead More